Mark Stahl

1.0k total citations
19 papers, 808 citations indexed

About

Mark Stahl is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mark Stahl has authored 19 papers receiving a total of 808 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 7 papers in Molecular Biology and 5 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mark Stahl's work include Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological diseases and metabolism (3 papers) and Developmental Biology and Gene Regulation (3 papers). Mark Stahl is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (7 papers), Neurological diseases and metabolism (3 papers) and Developmental Biology and Gene Regulation (3 papers). Mark Stahl collaborates with scholars based in United States, Germany and United Kingdom. Mark Stahl's co-authors include Shaolin Shi, Pamela Stanley, Jeff M. Bronstein, Changhui Ge, Kelley C. O’Donnell, Alvaro Sagasti, Aaron Lulla, Yuko Tashima, Kazuhide Uemura and Arthur G. Fitzmaurice and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Molecular and Cellular Biology.

In The Last Decade

Mark Stahl

18 papers receiving 800 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Stahl United States 12 394 217 143 129 111 19 808
Kayo Matsumoto Japan 16 323 0.8× 330 1.5× 201 1.4× 63 0.5× 177 1.6× 31 869
Yoshihiko Nakatani Japan 13 356 0.9× 117 0.5× 143 1.0× 89 0.7× 158 1.4× 30 669
Dianbo Qu Canada 18 720 1.8× 248 1.1× 219 1.5× 206 1.6× 155 1.4× 33 1.1k
Mary C. Maj Canada 15 479 1.2× 205 0.9× 122 0.9× 67 0.5× 115 1.0× 29 799
Liuwang Zeng China 18 455 1.2× 100 0.5× 85 0.6× 172 1.3× 134 1.2× 27 820
George K. E. Umanah United States 17 651 1.7× 167 0.8× 193 1.3× 171 1.3× 148 1.3× 19 1.0k
Pierre Dourlen France 15 500 1.3× 121 0.6× 216 1.5× 265 2.1× 299 2.7× 23 924
Núria Llecha Spain 13 561 1.4× 117 0.5× 191 1.3× 62 0.5× 66 0.6× 15 888
Jack C. Reidling United States 20 314 0.8× 257 1.2× 179 1.3× 105 0.8× 138 1.2× 30 866
Claus Zabel Germany 18 499 1.3× 97 0.4× 200 1.4× 100 0.8× 142 1.3× 31 801

Countries citing papers authored by Mark Stahl

Since Specialization
Citations

This map shows the geographic impact of Mark Stahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Stahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Stahl more than expected).

Fields of papers citing papers by Mark Stahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Stahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Stahl. The network helps show where Mark Stahl may publish in the future.

Co-authorship network of co-authors of Mark Stahl

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Stahl. A scholar is included among the top collaborators of Mark Stahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Stahl. Mark Stahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Stahl, Mark, et al.. (2020). H63D variant of the homeostatic iron regulator (HFE) gene alters α‐synuclein expression, aggregation, and toxicity. Journal of Neurochemistry. 155(2). 177–190. 7 indexed citations
3.
Connor, James R., et al.. (2018). Alpha-synuclein Protein Homeostasis and Oligomerization in Iron-overloaded Cells Expressing Mutant HFE (P3.059). Neurology. 90(15_supplement). 1 indexed citations
4.
Stella, S, et al.. (2017). Development of an acoustic-driven model of traumatic brain injury (TBI) in order to measure changes in the zebrafish retina and central visual pathways. Investigative Ophthalmology & Visual Science. 58(8). 5872–5872. 1 indexed citations
5.
Lucassen, Elisabeth B., et al.. (2017). Persistent Hemichorea and Caudate Atrophy in Untreated Diabetic Striatopathy: A Case Report. Case Reports in Neurology. 9(3). 299–303. 18 indexed citations
6.
Lulla, Aaron, Lisa M. Barnhill, Gal Bitan, et al.. (2016). Neurotoxicity of the Parkinson Disease-Associated Pesticide Ziram Is Synuclein-Dependent in Zebrafish Embryos. Environmental Health Perspectives. 124(11). 1766–1775. 62 indexed citations
7.
Wu, Ning, et al.. (2015). Recurrent Episodes of Stroke-Like Symptoms in a Patient with Charcot-Marie-Tooth Neuropathy X Type 1. Case Reports in Neurology. 7(3). 247–252. 6 indexed citations
8.
Stahl, Mark, et al.. (2015). Capgras Syndrome in a Patient with Parkinson's Disease after Bilateral Subthalamic Nucleus Deep Brain Stimulation: A Case Report. Case Reports in Neurology. 7(2). 127–133. 8 indexed citations
9.
O’Donnell, Kelley C., et al.. (2014). Axon degeneration and PGC1α-mediated protection in a vertebrate model of α-synuclein toxicity. Disease Models & Mechanisms. 7(5). 571–82. 72 indexed citations
10.
Prabhudesai, Shubhangi, Sharmistha Sinha, Aida Attar, et al.. (2012). A Novel “Molecular Tweezer” Inhibitor of α-Synuclein Neurotoxicity in Vitro and in Vivo. Neurotherapeutics. 9(2). 464–476. 126 indexed citations
11.
Fitzmaurice, Arthur G., Shannon Rhodes, Aaron Lulla, et al.. (2012). Aldehyde dehydrogenase inhibition as a pathogenic mechanism in Parkinson disease. Proceedings of the National Academy of Sciences. 110(2). 636–641. 152 indexed citations
12.
Chandrasekharan, Kumaran, Shaolin Shi, Mark Stahl, et al.. (2008). O-fucosylation of muscle agrin determines its ability to cluster acetylcholine receptors. Molecular and Cellular Neuroscience. 39(3). 452–464. 31 indexed citations
13.
Stahl, Mark, Kazuhide Uemura, Changhui Ge, et al.. (2008). Roles of Pofut1 and O-Fucose in Mammalian Notch Signaling. Journal of Biological Chemistry. 283(20). 13638–13651. 147 indexed citations
14.
Stahl, Mark, Changhui Ge, Shaolin Shi, Richard G. Pestell, & Pamela Stanley. (2006). Notch1-Induced Transformation of RKE-1 Cells Requires Up-regulation of Cyclin D1. Cancer Research. 66(15). 7562–7570. 40 indexed citations
15.
Shi, Shaolin, Mark Stahl, Linchao Lu, & Pamela Stanley. (2005). Canonical Notch Signaling Is Dispensable for Early Cell Fate Specifications in Mammals. Molecular and Cellular Biology. 25(21). 9503–9508. 48 indexed citations
16.
Moadel, Renée M., Richard Weldon, Ellen B. Katz, et al.. (2005). Positherapy: Targeted Nuclear Therapy of Breast Cancer with 18F-2-Deoxy-2-Fluoro-d-Glucose. Cancer Research. 65(3). 698–702. 42 indexed citations
17.
D’Amico, Mark, Kongming Wu, Dolores Di Vizio, et al.. (2003). The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.. PubMed. 63(12). 3395–402. 25 indexed citations
19.
Stahl, Mark, et al.. (1984). [5-day seizures of the newborn infant. A new disease picture].. PubMed. 132(10). 786–90. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026